RefleXion Receives FDA Clearance for SCINTIX Biology-Guided Radiotherapy
RefleXion Medical, a therapeutic oncology company, today announced the U.S. Food and Drug Administration (FDA) has granted the first marketing clearance for its SCINTIX™ biology-guided radiotherapy, a cutting-edge treatment applicable…